My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 102

1.

Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.

Umpierrez GE, Jones S, Smiley D, Mulligan P, Keyler T, Temponi A, Semakula C, Umpierrez D, Peng L, Cerón M, Robalino G.

Diabetes Care. 2009 Jul;32(7):1164-9. Epub 2009 Apr 14.PMID: 19366972 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.

Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, E Kitabchi A.

Am J Med. 2004 Sep 1;117(5):291-6.PMID: 15336577 [PubMed - indexed for MEDLINE]Related articles

3.

Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.

Yeldandi RR, Lurie A, Baldwin D.

Diabetes Technol Ther. 2006 Dec;8(6):609-16.PMID: 17109592 [PubMed - indexed for MEDLINE]Related articles

4.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.PMID: 15189747 [PubMed - indexed for MEDLINE]Related articles

5.

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB.

Diabetes Care. 2001 Apr;24(4):631-6.PMID: 11315821 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.

Clin Ther. 2004 May;26(5):724-36.PMID: 15220016 [PubMed - indexed for MEDLINE]Related articles

7.

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA.

Diabetes Care. 2000 May;23(5):639-43.PMID: 10834423 [PubMed - indexed for MEDLINE]Related articlesFree article

8.

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.

Diabetes Care. 2003 May;26(5):1490-6.PMID: 12716810 [PubMed - indexed for MEDLINE]Related articlesFree article

9.

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

Raskin P, Klaff L, Bergenstal R, Hallé JP, Donley D, Mecca T.

Diabetes Care. 2000 Nov;23(11):1666-71.PMID: 11092290 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.

Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE.

Diabetes Care. 2004 Aug;27(8):1873-8.PMID: 15277410 [PubMed - indexed for MEDLINE]Related articlesFree article

11.

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators.

Diabetes Care. 2003 Nov;26(11):3080-6.PMID: 14578243 [PubMed - indexed for MEDLINE]Related articlesFree article

12.

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.

Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Järvinen H.

Diabetes Care. 2005 Feb;28(2):254-9.PMID: 15677775 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

Rosenstock J, Park G, Zimmerman J; U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

Diabetes Care. 2000 Aug;23(8):1137-42.PMID: 10937511 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

Clin Ther. 2008 Aug;30(8):1476-84.PMID: 18803989 [PubMed - indexed for MEDLINE]Related articles

15.

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Yki-Järvinen H, Dressler A, Ziemen M; HOE 901/300s Study Group.

Diabetes Care. 2000 Aug;23(8):1130-6.PMID: 10937510 [PubMed - indexed for MEDLINE]Related articlesFree article

16.

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA.

Diabetologia. 2004 Apr;47(4):622-9.PMID: 15298338 [PubMed - indexed for MEDLINE]Related articles

17.

Insulin glulisine provides improved glycemic control in patients with type 2 diabetes.

Dailey G, Rosenstock J, Moses RG, Ways K.

Diabetes Care. 2004 Oct;27(10):2363-8.PMID: 15451901 [PubMed - indexed for MEDLINE]Related articlesFree article

18.

Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).

Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T.

Endocr J. 2007;54(6):975-83. Epub 2007 Nov 14.PMID: 18000343 [PubMed - indexed for MEDLINE]Related articlesFree article

19.

Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.

Porcellati F, Rossetti P, Pampanelli S, Fanelli CG, Torlone E, Scionti L, Perriello G, Bolli GB.

Diabet Med. 2004 Nov;21(11):1213-20.PMID: 15498088 [PubMed - indexed for MEDLINE]Related articles

20.

Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients.

Pan CY, Sinnassamy P, Chung KD, Kim KW; LEAD Study Investigators Group.

Diabetes Res Clin Pract. 2007 Apr;76(1):111-8. Epub 2006 Oct 2.PMID: 17011662 [PubMed - indexed for MEDLINE]Related articles

Supplemental Content

Filter your results:

Find related data

Recent activity